BC Investments plans 2% stake sale in Emcure Pharma
after close1 source ↓written by the desknot a recommendation
- valued
- ₹493 crore
- per share
- ₹1,296.51
- to the stock's
- 7% discount
- on the NSE
- ₹1,394.10
- for the sold
- 90-day lock-in period
BC Investments is set to sell up to 2% of Emcure Pharmaceuticals through a block deal, valued at ₹493 crore. The indicative floor price is ₹1,296.51 per share, reflecting a 7% discount to the stock's last closing price of ₹1,394.10 on the NSE. This transaction includes a 90-day lock-in period for the sold shares.
Not investment advice. For informational purposes only.